Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,664,825
+$8,573 QoQ
Shares Held
97,451
+0.1% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#101
of 329 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. PCVX ranks #45 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in PCVX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,664,825 | 97,451 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,656,252 | 97,337 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $5,550,687 | 120,301 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $4,697,043 | 130,401 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,342,099 | 133,562 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,903,965 | 129,872 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $10,123,133 | 123,664 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $11,373,063 | 99,528 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $7,272,367 | 96,310 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $6,474,626 | 94,783 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $5,024,187 | 80,003 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $3,845,421 | 75,430 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,524,714 | 70,579 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,478,251 | 66,122 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,261,899 | 26,317 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $377,856 | 15,744 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $335,865 | 15,435 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $213,582 | 8,844 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $193,103 | 8,117 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $209,454 | 8,256 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $93,011 | 4,132 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $71,948 | 3,643 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $71,658 | 2,697 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $102,265 | 2,071 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||